New cancer therapies

Chair: Caroline Springer, CRUK Manchester Institute, UK
Speaker: Ian Collins, The Institute of Cancer Research, UK
Speaker: John Bell, University of Ottawa, Canada
Speaker: Allan Jordan, CRUK Manchester Institute, UK


Room: Boisdale

This session will cover several aspects of biological and small molecule cancer drug discovery, from target validation to preclinical development. Understand how the drug discovery process starts and progresses towards the clinic. The aim is to become familiar with different strategies to target cancer.